2016
DOI: 10.5152/turkpediatriars.2016.3956
|View full text |Cite
|
Sign up to set email alerts
|

Salmonella Glomerulonephritis and Haemophagocytic Lymphohistiocytosis in an adolescent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…Juanita Uribe-Londono et al reported a sHLH patient triggered by S.typhi was treated by piperacillin-tazobactam, intravenous immunoglobulin, and cipro oxacin, who completed 14 days of antibiotic treatment and discharged from hospital [12]. Arslansoyu Çamlar et al reported an early diagnosis of S.typhi, treatment with parenteral ceftriaxon and supportive treatment prevented progression of HLH [13]. Caksen et al reported a sHLH patient associated with typhoid fever was given oral chloramphenicol for 14 days, who was symptom-free during a 7-month of follow-up [14].…”
Section: Discussionmentioning
confidence: 99%
“…Juanita Uribe-Londono et al reported a sHLH patient triggered by S.typhi was treated by piperacillin-tazobactam, intravenous immunoglobulin, and cipro oxacin, who completed 14 days of antibiotic treatment and discharged from hospital [12]. Arslansoyu Çamlar et al reported an early diagnosis of S.typhi, treatment with parenteral ceftriaxon and supportive treatment prevented progression of HLH [13]. Caksen et al reported a sHLH patient associated with typhoid fever was given oral chloramphenicol for 14 days, who was symptom-free during a 7-month of follow-up [14].…”
Section: Discussionmentioning
confidence: 99%
“…HIV, malnutrition [ 2 ], [ 4 ], [ 10 ], [ 13 ], [ 14 ]; structural and functional abnormalities, e.g. malignant tumours [ 15 ], haemoglobinopathies (Sickle cell disease) [ 16 ], [ 17 ], cysts [ 18 ], neurologic disorders [ 19 ]; infants/young children, elderly patients [ 2 ], [ 4 ], [ 10 ], [ 13 ]; patients with limited access to proper health care, e.g. patients from remote areas or low-income countries, patients affected by poverty [ 2 ], [ 4 ], [ 13 ]; delay in diagnosis and treatment [ 2 ], [ 4 ], [ 13 ]; inappropriate antibiotic treatment, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…structural and functional abnormalities, e.g. malignant tumours [ 15 ], haemoglobinopathies (Sickle cell disease) [ 16 ], [ 17 ], cysts [ 18 ], neurologic disorders [ 19 ];…”
Section: Introductionmentioning
confidence: 99%